☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Goldfinch Bio
Goldfinch Bio Reports Preliminary Results of GFB-887 in P-II (TRACTION-2) Trial for Focal Segmental Glomerular Sclerosis & Diabeti...
March 1, 2022
PharmaShots Weekly Snapshots (May 10 - 14, 2021)
May 14, 2021
Load more...
Back to Home
Modal title
×
Modal body text goes here.